Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors

Acute myeloid leukemia (AML) is among the top four malignancies in Saudi nationals, and it is the top leukemia subtype worldwide. Resistance to available AML drugs requires the identification of new targets and agents. Hsp90 is one of the emerging important targets in AML, which has a central role i...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdalla, Ashraf N., Abdallah, Mohamed E., Aslam, Akhmed, Bader, Ammar, Vassallo, Antonio, Tommasi, Nunziatina De, Malki, Waleed H., Gouda, Ahmed M., Mukhtar, Mohammed H., El-Readi, Mahmoud Zaki, Alkahtani, Hamad M., Abdel-Aziz, Alaa A.-M., El-Azab, Adel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248782/
https://www.ncbi.nlm.nih.gov/pubmed/32397330
http://dx.doi.org/10.3390/molecules25092220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248782/
https://www.ncbi.nlm.nih.gov/pubmed/32397330
http://dx.doi.org/10.3390/molecules25092220

Ejemplares similares